Showing results (121-130 of 140) with videos related to
Sort By:
Pageof 14
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2018
Optimizing Time to Treatment to Achieve Durable Biochemical Disease Control after Surgery in Prostate Cancer: A Multi-Institutional Cohort StudyShivanshu Awasthi, Travis Gerke, Jong Y Park, et al.Prostate Cancer and Prostatic Diseases|February 23, 2022
Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysisShivanshu Awasthi, Brandon A Mahal, Jong Y Park, et al.Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Prostate CancerR R Bahnson, G E Hanks, R P Huben, et al.Proceedings of the National Academy of Sciences of the United States of America|July 20, 2000
New roles for cis-jasmone as an insect semiochemical and in plant defenseM A Birkett, C A Campbell, K Chamberlain, et al.Oncoimmunology|September 20, 2018
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancerMichael Poch, MacLean Hall, Autumn Joerger, et al.Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 23, 2023
Recruiting African American Prostate Cancer Survivors for a Population-based Biobank StudyXiaoyin Li, Siddhartha Roy, Jennifer Damonte, et al.European Urology|December 11, 2020
Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate CancerKosj Yamoah, Shivanshu Awasthi, Brandon A Mahal, et al.Nature Medicine|November 9, 2024
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trialRoger Li, Nancy Y Villa, Xiaoqing Yu, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2013
Prostate cancer, version 1.2014James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.Pageof 14